Trelegy Ellipta filing accepted by EMA for asthma by Anna Smith | Feb 28, 2020 | News | 0 As it stands there is no single inhaled triple therapy available for the treatment of asthma in Europe. Read More
GSK picks Kevin Sim to lead business development for pharma R&D by Selina McKee | Apr 19, 2018 | News | 0 GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D. Read More